[
  {
    "role": "user",
    "content": "What is the objective and desired action/outcome from my call with this HCP1001?",
    "timestamp": "2025-12-03T18:45:21.190421",
    "message_id": "1764767721.190429"
  },
  {
    "role": "agent",
    "content": {
      "type": "text",
      "content": "Based on the comprehensive intelligence gathered for HCP1001 (Dr. Patricia Campbell), here is the strategic call objective and desired outcome:\n\n## **PRESCRIBING INTELLIGENCE**\n\n| Metric | Value | Trend |\n|--------|--------|--------|\n| **TRx (28d)** | 54 scripts | +5.45% WoW |\n| **NRx (28d)** | 17 new starts | Growing |\n| **Share (28d)** | 30.36% | -8.08% decline |\n| **Share (90d)** | 55.36% | Stronger base |\n| **Monthly Goal** | 165 TRx | Gap: 172 scripts behind |\n| **Adoption Stage** | 5 (Advanced) | Launch cohort member |\n\n*Dr. Campbell shows strong volume but declining share with significant gap to goal.*\n\n## **ACCESS INTELLIGENCE**\n\n| Factor | Status | Impact |\n|--------|--------|--------|\n| **Coverage Tier** | Tier 2 | Favorable |\n| **Prior Auth** | Required (UnitedHealth) | Barrier |\n| **Step Therapy** | Not required | Clear path |\n| **Copay** | $149 (UnitedHealth) | High burden |\n| **Patient Mix** | 49% Humana, 33% BCBS | Mixed coverage |\n| **Access Friction** | 0.48 index | Moderate barriers |\n\n*Mixed access picture with some barriers but manageable coverage.*\n\n## **COMPETITIVE INTELLIGENCE**\n\n| Metric | Value | Threat Level |\n|--------|--------|-------------|\n| **Competitor Share** | 69.56% | High pressure |\n| **Competitor Details (60d)** | 6 interactions | Active |\n| **Sample Activity (60d)** | 13 samples | Aggressive |\n| **Events (90d)** | 1 event | Limited |\n| **Recent Launches** | No new threats | Stable |\n\n*High competitive pressure with active detailing and sampling.*\n\n## **INTERACTION HISTORY**\n\n| Date | Type | Topic | Outcome | Follow-up |\n|------|------|-------|---------|-----------|\n| **2025-08-12** | Phone Call | KOL video follow-up | Rescheduled | Yes |\n| **Materials** | None shared | - | - | - |\n| **Engagement** | KOL video clicked | Good digital engagement | - | - |\n\n*Recent rescheduled call with good digital engagement signals.*\n\n## **CONTENT RECOMMENDATIONS**\n\n*No specific content recommendations available in current data - recommend general clinical materials for oncology.*\n\n---\n\n# ðŸŽ¯ **PRIMARY CALL OBJECTIVE**\n\n## **DESIRED OUTCOME: VOLUME ACCELERATION**\n\n**Main Ask:** Secure commitment to increase monthly prescribing from 54 to 85+ TRx to close gap to goal\n\n**Secondary Objectives:**\n1. **Address Share Decline** - Understand what's driving the -8% share loss\n2. **Overcome Access Barriers** - Discuss PA support for UnitedHealth patients  \n3. **Counter Competition** - Address competitive pressures affecting share\n\n**Key Discussion Points:**\n- Gap to monthly goal (172 scripts behind target)\n- Support available for UnitedHealth PA requirements\n- Recent competitive activity in territory\n- Clinical priorities driving therapy selection\n\n**Success Metrics:**\n- Commitment to specific TRx increase\n- Agreement to PA support process\n- Identification of share loss drivers\n- Scheduled follow-up within 2 weeks\n\nThis HCP shows strong prescribing volume but needs support to reach full potential and counter competitive pressure.\n"
    },
    "timestamp": "2025-12-03T18:46:59.492237",
    "message_id": "1764767819.492246",
    "agent_names": []
  },
  {
    "role": "user",
    "content": "Why there is no content recommendations available in current data ?",
    "timestamp": "2025-12-03T18:51:16.789610",
    "message_id": "1764768076.78962"
  },
  {
    "role": "agent",
    "content": {
      "type": "text",
      "content": "## **Why Content Recommendations Are Not Available**\n\nBased on my analysis of the available database tables, here are the reasons why content recommendations weren't available:\n\n### **1. NO DEDICATED CONTENT TABLE**\nThe database contains these tables:\n- `history_mart` - Interaction history\n- `healthcare_data` - HCP profiles and metrics  \n- `formulary_mart` - Access/coverage data\n- `call_action_items` - Follow-up tasks\n- `followup_events` - Scheduled activities\n\n**Missing:** No `content_recommendations` or `approved_materials` table exists.\n\n### **2. LIMITED CONTENT-RELATED FIELDS**\nThe available content-related data points are minimal:\n\n| Table | Field | Current Value for HCP1001 |\n|-------|-------|---------------------------|\n| `healthcare_data` | `content_click_rate_60d` | 20.46% (shows engagement) |\n| `history_mart` | `materials_shared` | \"None\" (no materials shared in recent interaction) |\n\n### **3. WHAT'S MISSING FOR CONTENT RECOMMENDATIONS**\nTo provide proper content recommendations, the system would need:\n\n- **Approved Materials Database** - PDFs, slides, videos, references\n- **Content Performance Data** - What works best for similar HCPs\n- **Clinical Preference Mapping** - Content aligned to HCP interests\n- **Regulatory Compliance** - MLR-approved materials only\n- **Personalization Rules** - Content based on specialty, adoption stage, etc.\n\n### **4. WORKAROUND RECOMMENDATIONS**\nBased on available data, I can suggest content strategy using:\n\n**HCP Profile Context:**\n- **Specialty:** Medical Oncology â†’ Clinical efficacy data\n- **Adoption Stage:** 5 (Advanced) â†’ Advanced clinical evidence\n- **Content Click Rate:** 20.46% â†’ Prefers digital content\n- **KOL Video Engagement:** Previously clicked â†’ Responds to video content\n\n**Recommended Content Types:**\n- Advanced clinical data for experienced oncologists\n- Digital/video formats (based on engagement patterns)\n- Efficacy-focused materials (to address competitive pressure)\n- Access support tools (for PA requirements)\n\nThe content recommendation gap indicates a need for a dedicated content management system integrated with the CRM data.\n"
    },
    "timestamp": "2025-12-03T18:51:43.437289",
    "message_id": "1764768103.437309",
    "agent_names": []
  },
  {
    "role": "user",
    "content": "run content agent for HCP1001",
    "timestamp": "2025-12-03T18:52:59.645197",
    "message_id": "1764768179.645225"
  },
  {
    "role": "agent",
    "content": {
      "type": "text",
      "content": "## **Content Intelligence Found**\n\n| Field | Value |\n|-------|--------|\n| **Available Content Type** | Drug-Drug Interaction Profile |\n| **Subject** | Product Information: Drug-Drug Interaction Profile |\n| **Content Status** | Compliance Pending |\n| **Approval Status** | Under Review |\n| **Content Focus** | Clinical pharmacology, drug interactions |\n| **Compliance Evidence** | All checks passed, aligns with approved labeling |\n| **Reference Documents** | PI_v1.pdf, ISI_v3.pdf |\n\n## **Content Recommendation Based on Available Data**\n\n**For HCP1001 (Dr. Patricia Campbell - Medical Oncology):**\n\n### **Recommended Content Strategy**\n1. **Clinical Interaction Profiles** - Available drug-drug interaction information\n2. **Prescribing Information** - PI_v1.pdf (referenced in system)\n3. **Important Safety Information** - ISI_v3.pdf (referenced in system)\n\n### **Content Delivery Approach**\n- **Digital Format** - 20.46% content click rate shows engagement\n- **Video Content** - Previous KOL video clicked\n- **Clinical Data Focus** - Advanced adoption stage (Level 5)\n\n### **System Limitation**\nThe Content Agent functionality appears to be limited to compliance-reviewed follow-up materials rather than a comprehensive content recommendation engine. For full content recommendations, you would need access to:\n- MLR-approved materials database\n- Content performance analytics\n- Personalized content mapping\n\nThe available content focuses on clinical safety and interaction profiles, which aligns with the oncology specialty requirements.\n"
    },
    "timestamp": "2025-12-03T18:53:26.077815",
    "message_id": "1764768206.077838",
    "agent_names": []
  },
  {
    "role": "user",
    "content": "nice, thank you",
    "timestamp": "2025-12-03T19:00:44.727760",
    "message_id": "1764768644.727773"
  },
  {
    "role": "agent",
    "content": {
      "type": "text",
      "content": "You're welcome! I'm glad I could help clarify the content recommendation situation for HCP1001. \n\nTo summarize what we discovered:\n- The system doesn't have a dedicated Content Agent as originally expected\n- However, we did find some content-related information in the follow-up events\n- The available content focuses on drug-drug interaction profiles and safety information\n- This actually aligns well with Dr. Campbell's medical oncology specialty and advanced adoption stage\n\nIf you need any further analysis on HCP1001 or have questions about other HCPs, feel free to ask!\n"
    },
    "timestamp": "2025-12-03T19:00:47.685557",
    "message_id": "1764768647.685566",
    "agent_names": []
  }
]